Bertrand DELSUC / Biotellytics / @bertrandbio Compilation of abstract titles from ASCO Annual Meeting 2021 (oral, poster discussion, posters, mains track by cancer types only) Table of Content I. ORAL PRESENTATIONS ............................................................................................................................................ 4 Plenary Session ........................................................................................................................................................... 4 Developmental Therapeutics—Molecularly Targeted Agents and Tumor Biology ...................................... 7 Lung Cancer—Non-Small Cell Metastatic ............................................................................................................ 10 Sarcoma ...................................................................................................................................................................... 13 Hematologic Malignancies—Leukemia, Myelodysplastic Syndromes, and Allotransplant ...................... 15 Pediatric Oncology I ................................................................................................................................................. 18 Melanoma/Skin Cancers ......................................................................................................................................... 21 Lung Cancer—Non-Small Cell Local-Regional/Small Cell/Other Thoracic Cancers .................................... 25 Breast Cancer—Local/Regional/Adjuvant ........................................................................................................... 28 Gastrointestinal Cancer—Gastroesophageal, Pancreatic, and Hepatobiliary ............................................ 32 Breast Cancer—Metastatic ..................................................................................................................................... 35 Central Nervous System Tumors .......................................................................................................................... 39 Genitourinary Cancer—Kidney and Bladder ...................................................................................................... 42 Gynecologic Cancer .................................................................................................................................................. 45 Hematologic Malignancies—Lymphoma and Chronic Lymphocytic Leukemia .......................................... 49 Gastrointestinal Cancer—Colorectal and Anal .................................................................................................. 52 Head and Neck Cancer ............................................................................................................................................ 56 Developmental Therapeutics—Immunotherapy............................................................................................... 59 1 Bertrand DELSUC / Biotellytics / @bertrandbio Genitourinary Cancer—Prostate, Testicular, and Penile ................................................................................. 62 Hematologic Malignancies—Plasma Cell Dyscrasia.......................................................................................... 65 II. POSTER DISCUSSION PRESENTATIONS ................................................................................................................. 69 Central Nervous System Tumors .......................................................................................................................... 69 Developmental Therapeutics—Immunotherapy............................................................................................... 72 Gastrointestinal Cancer—Colorectal and Anal .................................................................................................. 76 Gastrointestinal Cancer—Gastroesophageal, Pancreatic, and Hepatobiliary ............................................ 79 Genitourinary Cancer—Kidney and Bladder ...................................................................................................... 83 Genitourinary Cancer—Prostate, Testicular, and Penile ................................................................................. 86 Gynecologic Cancer .................................................................................................................................................. 90 Head and Neck Cancer ............................................................................................................................................ 94 Hematologic Malignancies—Leukemia, Myelodysplastic Syndromes, and Allotransplant ...................... 97 Hematologic Malignancies—Lymphoma and Chronic Lymphocytic Leukemia ........................................ 100 Hematologic Malignancies—Plasma Cell Dyscrasia........................................................................................ 103 Lung Cancer—Non-Small Cell Local-Regional/Small Cell/Other Thoracic Cancers .................................. 107 Lung Cancer—Non-Small Cell Metastatic .......................................................................................................... 110 Melanoma/Skin Cancers ....................................................................................................................................... 114 Pediatric Oncology ................................................................................................................................................. 117 Sarcoma .................................................................................................................................................................... 120 Pediatric Oncology II .............................................................................................................................................. 124 III. POSTER PRESENTATIONS ................................................................................................................................ 127 Breast Cancer—Local/Regional/Adjuvant ......................................................................................................... 127 Breast Cancer—Metastatic ................................................................................................................................... 145 Central Nervous System Tumors ........................................................................................................................ 166 Developmental Therapeutics—Immunotherapy............................................................................................. 176 Developmental Therapeutics—Molecularly Targeted Agents and Tumor Biology .................................. 212 Gastrointestinal Cancer—Colorectal and Anal ................................................................................................ 242 Gastrointestinal Cancer—Gastroesophageal, Pancreatic, and Hepatobiliary .......................................... 265 Genitourinary Cancer—Kidney and Bladder .................................................................................................... 301 Genitourinary Cancer—Prostate, Testicular, and Penile ............................................................................... 320 2 Bertrand DELSUC / Biotellytics / @bertrandbio Gynecologic Cancer ................................................................................................................................................ 338 Head and Neck Cancer .......................................................................................................................................... 357 Hematologic Malignancies—Leukemia, Myelodysplastic Syndromes, and Allotransplant .................... 375 Hematologic Malignancies—Lymphoma and Chronic Lymphocytic Leukemia ........................................ 383 Hematologic Malignancies—Plasma Cell Dyscrasia........................................................................................ 396 Lung Cancer—Non-Small Cell Local-Regional/Small Cell/Other Thoracic Cancers .................................. 405 Lung Cancer—Non-Small Cell Metastatic .......................................................................................................... 421 Melanoma/Skin Cancers ....................................................................................................................................... 446 Pediatric Oncology ................................................................................................................................................. 463 Sarcoma .................................................................................................................................................................... 469 3 Bertrand DELSUC / Biotellytics / @bertrandbio I. ORAL PRESENTATIONS Plenary Session Sunday, June 6,7:00 PM - 10:00 PM CEST Back to Program Showing 17 Presentations https://meetinglibrary.asco.org/session/13668 Chair CHAIR Norah Lynn Henry, MD, PhD, FASCO, FACP | University of Michigan Chair CHAIR Lori J. Pierce, MD, FASTRO, FASCO | University of Michigan OlympiA: A phase III, multicenter, randomized, placebo-controlled trial of adjuvant olaparib after (neo)adjuvant chemotherapy in patients with germline BRCA1/2 mutations and high-risk HER2-negative early breast cancer. AUTHOR(S) Andrew Tutt, Judy E. Garber, Bella Kaufman, Giuseppe Viale, Debora Fumagalli, Priya Rastogi, Richard D. Gelber, Evandro de Azambuja,